Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keyleaf is a value-added plant-based ingredient commercialization partner and contract development and manufacturing organization (CDMO). Formerly known as POS Bio-Sciences, the company specializes in the extraction, purification, and modification of plant-based materials for the food, nutraceutical, and cosmetic industries. With over four decades of experience, Keyleaf provides services ranging from bench-scale R&D to full-scale commercial production. The company operates advanced facilities in Canada and the United States, focusing on lipids, proteins, and other high-value plant derivatives. In 2019, Keyleaf was acquired by Canopy Growth Corporation to bolster its large-scale extraction and beverage production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keyleaf.